These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20805136)

  • 61. Pathway dysregulation analysis of the nucleotide excision repair mechanisms reveals it is not a common feature of melanomas.
    D'Arcy N; Matigian N; Lê Cao KA; Gabrielli B
    Pigment Cell Melanoma Res; 2019 Mar; 32(2):336-338. PubMed ID: 30269428
    [No Abstract]   [Full Text] [Related]  

  • 62. Molecular bases of cutaneous and uveal melanomas.
    Gaudi S; Messina JL
    Patholog Res Int; 2011; 2011():159421. PubMed ID: 21876842
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.
    Chen X; Wu Q; Tan L; Porter D; Jager MJ; Emery C; Bastian BC
    Oncogene; 2014 Sep; 33(39):4724-34. PubMed ID: 24141786
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutations in GNA11 in uveal melanoma.
    Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
    N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population.
    Yilmaz I; Gamsizkan M; Kucukodaci Z; Berber U; Demirel D; Haholu A; Narli G
    Indian J Pathol Microbiol; 2015; 58(3):279-84. PubMed ID: 26275246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.
    Huang JL; Urtatiz O; Van Raamsdonk CD
    Cancer Res; 2015 Aug; 75(16):3384-97. PubMed ID: 26113083
    [TBL] [Abstract][Full Text] [Related]  

  • 67. GNAQ and GNA11 mutations in uveal melanoma.
    Shoushtari AN; Carvajal RD
    Melanoma Res; 2014 Dec; 24(6):525-34. PubMed ID: 25304237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.
    Xu X; Wei WB; Li B; Gao F; Zhang Z; Jonas JB
    PLoS One; 2014; 9(10):e109699. PubMed ID: 25280020
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
    Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
    Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of mutant GNAQ signaling in uveal melanoma induces AMPK-dependent autophagic cell death.
    Ambrosini G; Musi E; Ho AL; de Stanchina E; Schwartz GK
    Mol Cancer Ther; 2013 May; 12(5):768-76. PubMed ID: 23443802
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.
    Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE
    Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
    Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
    Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver.
    Ramos R; Vinyals A; Campos-Martin R; Cabré E; Bech JJ; Vaquero J; Gonzalez-Sanchez E; Bertran E; Ferreres JR; Lorenzo D; De La Torre CG; Fabregat I; Caminal JM; Fabra À
    Cancers (Basel); 2024 Aug; 16(17):. PubMed ID: 39272836
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biological characteristics and clinical management of uveal and conjunctival melanoma.
    Kaštelan S; Pavičić AD; Pašalić D; Nikuševa-Martić T; Čanović S; Kovačević P; Konjevoda S
    Oncol Res; 2024; 32(8):1265-1285. PubMed ID: 39055896
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ.
    Schrenk S; Bischoff LJ; Goines J; Cai Y; Vemaraju S; Odaka Y; Good SR; Palumbo JS; Szabo S; Reynaud D; Van Raamsdonk CD; Lang RA; Boscolo E
    Nat Commun; 2023 Apr; 14(1):1929. PubMed ID: 37024491
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetics and RNA Regulation of Uveal Melanoma.
    Barbagallo C; Stella M; Broggi G; Russo A; Caltabiano R; Ragusa M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765733
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    Silva-Rodríguez P; Fernández-Díaz D; Bande M; Pardo M; Loidi L; Blanco-Teijeiro MJ
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MITF deficiency accelerates GNAQ-driven uveal melanoma.
    Phelps GB; Hagen HR; Amsterdam A; Lees JA
    Proc Natl Acad Sci U S A; 2022 May; 119(19):e2107006119. PubMed ID: 35512098
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Uveal melanoma: progress in molecular biology and therapeutics.
    Li Y; Shi J; Yang J; Ge S; Zhang J; Jia R; Fan X
    Ther Adv Med Oncol; 2020; 12():1758835920965852. PubMed ID: 33149769
    [TBL] [Abstract][Full Text] [Related]  

  • 80. miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1.
    Peng D; Dong J; Zhao Y; Peng X; Tang J; Chen X; Wang L; Hu DN; Reinach PS; Qu J; Yan D
    Cancer Manag Res; 2019; 11():4729-4742. PubMed ID: 31213897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.